ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
17.2571
1.57%
Brent Oil
81.195
0.48%
Bitcoin
69,065.24
1.94%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. 10x Genomics Inc (TXG)

  7. 10x Genomics Inc (TXG) Noticias

TXG 10x Genomics Inc

22.42
0.00 (0.00%)
Pre Mercado
Última actualización: 03:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
10x Genomics Inc TXG NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 22.42 03:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
22.42
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
31/5/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202415:05PRNUS10x Genomics Launches 5,000-Plex Gene Panel for Xenium
23/5/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202418:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202418:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:27EDGAR2Form 144 - Report of proposed sale of securities
22/5/202415:23EDGAR2Form 144 - Report of proposed sale of securities
22/5/202415:17EDGAR2Form 144 - Report of proposed sale of securities
02/5/202415:05PRNUS10x Genomics to Present at the BofA Securities 2024..
30/4/202415:05PRNUS10x Genomics Reports First Quarter 2024 Financial Results
10/4/202415:05PRNUS10x Genomics to Report First Quarter 2024 Financial Results..
26/3/202408:00PRNUS10x Genomics Commercially Launches Visium HD Spatial Gene..
21/3/202415:05PRNUS10x Genomics Expands Xenium Menu with Multi-Modal Cell..
13/3/202415:05PRNUS10x Genomics Begins Commercial Shipments of Chromium GEM-X..
06/3/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:40EDGAR2Form 144 - Report of proposed sale of securities
26/2/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202418:19EDGAR2Form 144 - Report of proposed sale of securities
22/2/202418:06EDGAR2Form 144 - Report of proposed sale of securities
22/2/202417:59EDGAR2Form 144 - Report of proposed sale of securities
20/2/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:05PRNUS10x Genomics to Present at the 44th Annual TD Cowen Health..
15/2/202416:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/2/202416:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202415:05EDGAR2Form 8-K - Current report
15/2/202415:05PRNUS10x Genomics Reports Fourth Quarter and Full Year 2023..
13/2/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:05PRNUS10x Genomics Expands Leadership in Single Cell Analysis with..
05/2/202415:05PRNUS10x Genomics to Showcase New Cutting-Edge Technologies and..
24/1/202415:05PRNUS10x Genomics to Report Fourth Quarter and Full Year 2023..
18/1/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202417:08EDGAR2Form 144 - Report of proposed sale of securities
16/1/202415:07EDGAR2Form 8-K - Current report
08/1/202408:00EDGAR2Form 8-K - Current report
08/1/202408:00PRNUS10x Genomics Announces Preliminary Fourth Quarter and Full..
29/12/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:05PRNUS10x Genomics to Present at the 42nd Annual J.P. Morgan..
20/12/202315:05PRNUS10x Genomics Launches Xenium Catalyst Network
19/12/202308:00PRNUSIntegrative Study Conducted by 10x Genomics Combines Single..
18/12/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202316:09EDGAR2Form 144 - Report of proposed sale of securities
13/12/202315:26PRNUSHigh Sensitivity and Specificity of the Xenium Platform from..
07/12/202308:00PRNUS10x Genomics and NIH CARD to Create Comprehensive Single..
27/11/202317:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202317:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202317:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202317:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
TXG
10x Genomics
TSXV
CNF
NYSE
EFS
TSXV
ROL.A
TSX
WELL
WELL Health Technologies
NASDAQ
NCOG
Nco
TG
AQE
Anhui Conch Cement
USOTC
WVFC
WVS Financial (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados